[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=57d8d4798b498b7f673a4d6a44baad655c471dbb8f8a9487fa8ca711e79b3574",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759941540,
      "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 137080673,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=57d8d4798b498b7f673a4d6a44baad655c471dbb8f8a9487fa8ca711e79b3574"
    }
  },
  {
    "ts": null,
    "headline": "Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know",
    "summary": "Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=6ec0c2e3253b1944188c250250bac75c42d99760d35462e60d18e81fca84fe1a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759928403,
      "headline": "Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know",
      "id": 137011031,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=6ec0c2e3253b1944188c250250bac75c42d99760d35462e60d18e81fca84fe1a"
    }
  },
  {
    "ts": null,
    "headline": "The Smartest Growth Stock to Buy With $500 Right Now",
    "summary": "Vertex isn't your run-of-the-mill biotech stock.",
    "url": "https://finnhub.io/api/news?id=b7d1601f505e2323183cd66b39980a8c408df39630c94d9f31bb3767725579e9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759912920,
      "headline": "The Smartest Growth Stock to Buy With $500 Right Now",
      "id": 137010168,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex isn't your run-of-the-mill biotech stock.",
      "url": "https://finnhub.io/api/news?id=b7d1601f505e2323183cd66b39980a8c408df39630c94d9f31bb3767725579e9"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q2 Earnings?",
    "summary": "Over the past six months, Vertex Pharmaceuticals’s stock price fell to $413.23. Shareholders have lost 12.5% of their capital, which is disappointing considering the S&P 500 has climbed by 34.7%. This might have investors contemplating their next move.",
    "url": "https://finnhub.io/api/news?id=378381ea5818c2a957ebc3285d8e0c33b0539746bf948463506b454bd9d68385",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759896192,
      "headline": "Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q2 Earnings?",
      "id": 137011032,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Over the past six months, Vertex Pharmaceuticals’s stock price fell to $413.23. Shareholders have lost 12.5% of their capital, which is disappointing considering the S&P 500 has climbed by 34.7%. This might have investors contemplating their next move.",
      "url": "https://finnhub.io/api/news?id=378381ea5818c2a957ebc3285d8e0c33b0539746bf948463506b454bd9d68385"
    }
  }
]